From Wikipedia, the free encyclopedia
|This article needs additional citations for verification. (August 2012) (Learn how and when to remove this template message)|
|Molar mass||170 kg/mol|
|(what is this?)|
This drug was developed by Medarex, Inc.
- Statement On A Nonproprietary Name Adopted By The USAN Council – Iratumumab, American Medical Association.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|